Recent advances in understanding the immune mechanisms of vitiligo are leading to new treatments for the disease. Current strategies include inhibiting T cell function and migration to the skin, as well as long-term survival of autoreactive memory T cells. An advanced understanding of cellular signaling within vitiligo lesions may lead to more advanced therapeutic approaches in the future.